Truist Financial Corp Takeda Pharmaceutical CO LTD Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Truist Financial Corp holds 84,456 shares of TAK stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,456

Previous 127,888 33.96%

Holding current value

$1.15 Million

Previous $1.65 Million 27.45%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.0 - $15.08 $564,616 - $654,954	-43,432 Reduced 33.96%	84,456 $1.2 Million
Q2 2024 Aug 20, 2024	SELL	$12.6 - $13.67 $88,174 - $95,662	-6,998 Reduced 5.19%	127,888 $1.65 Million
Q1 2024 May 10, 2024	SELL	$13.89 - $15.04 $1.01 Million - $1.1 Million	-72,933 Reduced 35.09%	134,886 $1.87 Million
Q4 2023 Feb 02, 2024	SELL	$13.36 - $15.43 $488,628 - $564,336	-36,574 Reduced 14.97%	207,819 $2.97 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $84,844 - $92,126	-5,645 Reduced 2.26%	244,393 $3.78 Million
Q2 2023 Aug 01, 2023	BUY	$15.57 - $17.11 $154,999 - $170,330	9,955 Added 4.15%	250,038 $3.93 Million
Q1 2023 May 05, 2023	BUY	$15.28 - $16.48 $1.13 Million - $1.22 Million	73,984 Added 44.54%	240,083 $3.96 Million
Q4 2022 Feb 17, 2023	BUY	$12.42 - $15.62 $1.08 Million - $1.36 Million	87,266 Added 110.7%	166,099 $2.59 Million
Q3 2022 Oct 26, 2022	SELL	$12.8 - $28.65 $83,481 - $186,855	-6,522 Reduced 7.64%	78,833 $1.02 Million
Q2 2022 Jul 22, 2022	BUY	$13.12 - $15.03 $63,290 - $72,504	4,824 Added 5.99%	85,355 $1.2 Million
Q1 2022 Apr 22, 2022	SELL	$13.54 - $15.35 $33,010 - $37,423	-2,438 Reduced 2.94%	80,531 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $139,299 - $173,462	-10,577 Reduced 11.31%	82,969 $1.13 Million
Q3 2021 Nov 05, 2021	SELL	$16.3 - $17.26 $33,659 - $35,641	-2,065 Reduced 2.16%	93,546 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $378,250 - $426,017	22,855 Added 31.41%	95,611 $1.61 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $193,785 - $230,780	-11,597 Reduced 13.75%	72,756 $1.33 Million
Q4 2020 Feb 18, 2021	SELL	$15.39 - $18.97 $208,395 - $256,872	-13,541 Reduced 13.83%	84,353 $1.54 Million
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $351,028 - $393,932	-20,528 Reduced 17.33%	97,894 $1.75 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $250,378 - $334,639	-17,161 Reduced 12.66%	118,422 $2.12 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $214,413 - $334,465	-16,468 Reduced 10.83%	135,583 $2.06 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $685,952 - $846,468	40,637 Added 36.47%	152,051 $3 Million
Q3 2019 Oct 31, 2019	BUY	$16.15 - $17.99 $87,177 - $97,110	5,398 Added 5.09%	111,414 $1.92 Million
Q2 2019 Jul 24, 2019	BUY	$16.58 - $20.49 $241,454 - $298,395	14,563 Added 15.92%	106,016 $1.88 Million
Q1 2019 Apr 23, 2019	BUY	$16.7 - $21.52 $486,053 - $626,339	29,105 Added 46.68%	91,453 $1.86 Million
Q4 2018 Jan 22, 2019	BUY	$15.64 - $21.1 $975,122 - $1.32 Million	62,348 New	62,348 $1.05 Million

Others Institutions Holding TAK

# of Institutions

336

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Takeda Pharmaceutical CO LTD Transaction History